CADL Candel Therapeutics, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Candel Therapeutics, Inc. (CADL) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 12, 2026, a 10-Q quarterly report filed on May 14, 2026, an 8-K current report filed on June 24, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Candel Therapeutics, Inc. (CADL) (SEC CIK 1841387), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Candel Therapeutics, Inc.
Ask AI about CADL filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting CADL positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on CADL.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Candel Therapeutics, Inc. (CADL) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jun 24, 2026 | - | - | - |
8-K | Jun 16, 2026 | - | - | - |
8-K | May 15, 2026 | - | - | |
10-Q | May 14, 2026 | Mar 31, 2026 | - | |
8-K | May 14, 2026 | - | - | |
8-K | Mar 12, 2026 | - | Analysis | - |
10-K | Mar 12, 2026 | Dec 31, 2025 | - | |
8-K | Feb 23, 2026 | - | Analysis | - |
8-K | Feb 19, 2026 | - | - | |
8-K | Dec 5, 2025 | - | - | |
10-Q | Nov 13, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 14, 2025 | Jun 30, 2025 | - | |
10-Q | May 13, 2025 | Mar 31, 2025 | - | |
10-K | Mar 13, 2025 | Dec 31, 2024 | - | |
SC 13G | Dec 17, 2024 | - | - | |
10-Q | Nov 14, 2024 | Sep 30, 2024 | - | |
10-Q | Aug 13, 2024 | Jun 30, 2024 | - | |
10-Q | May 14, 2024 | Mar 31, 2024 | - | |
10-K | Mar 28, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 10, 2023 | Jun 30, 2023 | - | |
10-Q | May 11, 2023 | Mar 31, 2023 | - | |
10-K | Mar 30, 2023 | Dec 31, 2022 | - | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | - | |
10-Q | Aug 5, 2022 | Jun 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate CADL share value held by 13F filers tracked by SignalX, by quarter.
- FMR LLC (Fidelity)+2.75M (+33%)
- BlackRock+247.4K (+9%)
- Goldman Sachs Group+162.4K (+250%)
- BNY Mellon+41.1K (+43%)
- Northern Trust+27.7K (+9%)
- Citadel Advisors LLC231.0K (-65%)
- Morgan Stanley75.8K (-57%)
- Wells Fargo & Co57.3K (-78%)
- Two Sigma Investments5.7K (-6%)
- Bank of America Corp3.9K (-8%)
- Millennium Management+1.06M
- AQR Capital Management+18.0K
- Renaissance Technologies LLC+12.8K
- U.S. Bancorp+731
- Vanguard Group Inc−2.31M
- JPMorgan Chase & Co−21.6K
- Invesco Ltd−15.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 112 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest CADL SEC filings in 2026?
Candel Therapeutics, Inc. (CADL) has filed a 10-K annual report on March 12, 2026, a 10-Q quarterly report on May 14, 2026, an 8-K current report on June 24, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CADL file its most recent 10-K annual report?
Candel Therapeutics, Inc. (CADL) filed its most recent 10-K annual report on March 12, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CADL 10-Q quarterly reports?
Candel Therapeutics, Inc. (CADL)'s most recent 10-Q quarterly report was filed on May 14, 2026. SignalX displays every CADL 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CADL filed recently?
Candel Therapeutics, Inc. (CADL)'s most recent 8-K was filed on June 24, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CADL insider trading activity (Form 4)?
SignalX aggregates every CADL Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CADL file with the SEC?
Candel Therapeutics, Inc. (CADL) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CADL filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Candel Therapeutics, Inc. (CADL).
What is CADL's SEC CIK number?
Candel Therapeutics, Inc. (CADL)'s SEC CIK (Central Index Key) number is 1841387. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1841387 to look up all CADL filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Candel Therapeutics, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 32+ filings.